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Abstract We have previously reported that 2'-O-methyl RNAs 
are efficient probes for duplex DNA. Here we describe the 
design, synthesis, and DNA cleaving activity of 1,10-pbenanthro- 
line (OP)-linked 2'-O-methyl RNA (OP-m). Although a local 
triple helix was formed, both with OP-m and a control OP- 
linked DNA at the target sequence of the duplex DNA, the 
promoter region of the human thrombomodulin gene, the 
cleavage fficiencies on both strands were not proportional when 
OP-m was used as a cleavage agent. These results may reflect 
the structural differences of the respective triple helices and the 
duplex-triplex junction, formed from the two types of triplex- 
forming oligonucleotides, 2'-O-methyl RNA and DNA. Since the 
OP-ms were found to work as preferential purine-strand cutters 
for duplex DNA, they would be useful as unique tools for genome 
analysis. 
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1. Introduction 
Homopyrimidine oligonucleotides recognize homopurine- 
homopyrimidine double-helical DNA through triple helix for- 
mation [1]. The specificity is imparted by Hoogsteen bond 
formation in the major groove of the DNA. To develop an 
effective probe for duplex DNA, several modifications of the 
bases or the phosphates of the triplex forming oligonucleo- 
tides (TFOs) have been made. We have reported that 2 ' -0-  
methyl RNAs are novel probes for duplex DNA, and that the 
triple helix structures formed from double-stranded DNA and 
T-O-methyl pyrimidine oligonucleotides show the highest 
thermal stability among the various 2'-substituted oligonu- 
cleotides: 2'-deoxy, 2'-fiuoro, and RNA [2]. A detailed ther- 
mal melting study using 2'-O-methyl RNAs, by Wang and 
Kool [3], supports our findings. Further investigations of 5- 
methyl analogs of 2'-O-methyl RNAs showed that a TFO 
containing 5-methyl-2'-O-methyluridine formed a more stable 
triple helix with the target DNA than the 5-unmodified parent 
probe [4]. In this study we converted T-O-methyl RNAs with 
a thiophosphate at the 5' end into chemical nucleases, which 
recognize the homopurine-homopyrimidine clusters in the 
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promoter region of the human thrombomodulin (TM) gene 
[5,6]. The DNA cleaving moiety was introduced into the 
TFOs by reaction with a thiol-specific agent bearing 1,10-phe- 
nanthroline (OP) [7]. 
2. Materials and methods 
2.1. Chemicals 
Oligonucleotides were synthesized on an Applied Biosystems (ABI) 
394 DNA/RNA synthesizer using the standard phosphoramidite 
method [8], with commercially available reagents (ABI for DNA) 
and 3'-(2-cyanoethyl)N,N-diisopropylphosphoramidite derivatives of 
2'-O-methyl ribonucleosides [9]. The phosphoramidite d rivative of 
N4-beuzoyl-5-methyl-2'-deoxycytidine was prepared as described pre- 
viously [7]. Oligonucleotides were purified by reverse phase HPLC 
using an Inertsil ODS-2 column (10 rum×250 ram, GL Science 
Inc.). Further purification was done by anion exchange HPLC using 
a TSK gel DEAE-2SW column (4.6 mm × 250 mm, Tosoh Co.). The 
synthesis and purification of the OP-linked oligonucleotides (OP-oli- 
gos) were conducted based on the reported procedures [7]. 
2.2. Preparation of 5' end-labeled double-stranded 50-mer DNAs 
Oligodeoxynucleotides (ODNs) corresponding to nucleotides 296- 
345 of the human TM promoter [5] were chemically synthesized and 
purified: d(CCAGGCACTTCCTTCCTTTCCCGAACGTCCAGG- 
GAGGGAGGGCCGGGCA) (coding strand) and its complementary 
strand (noncoding strand). Both strands were 5' end-labeled with 
[7-32p]ATP and T4 polynucleotide kinase (Takara Shuzo). The labeled 
strands were purified with a NENSORB 20 column (DuPont), and 
were annealed with the unlabeled complementary strand by heating at 
80°C for 10 min and then slowly cooling to room temperature. 
2.3. Cleavage of 50-met double-stranded DNAs 
A 4-I.tl solution of the target 50-mer duplex DNA (0.1 pmol) and 
the OP-oligo (10 pmol), in a buffer containing 12.5 mM Tris-acetate 
(pH 7.0), 125 mM NaC1, and 1.25 mM spermine.4HC1, was heated at 
70°C for 10 min and slowly cooled to 4°C for triple helix formation. 
10 ~tM copper sulfate (0.5 I.tl) was added and the solution was pre- 
incubated at 37°C for 1 h. The cleavage reaction was initiated by 
adding 50 mM I~-mercaptopropionic acid (MPA) (0.5 p J). The solu- 
tions of copper ion and MPA were freshly prepared in ultra-pure 
water, purified by a Milli-Q system (Millipore) and by a TORAY 
ion exchange fiber (TORAY PURE LV-08). The reaction mixture 
was incubated at 37°C for 20 h. The cleavage reaction was stopped 
by adding 100 ~tM neocuproine in ethanol (1 Ixl). This solution was 
mixed (1:2, v/v) with 80% deionized formamide containing 0.1% xy- 
lene cyauol and 0.1% bromophenol b ue. The samples were heated at 
80°C for 10 min and chilled in ice for denaturing. They were then 
loaded onto a 15% polyacrylamide g l (19:1, acrylamide/bisacryla- 
mide, 40 cm long) containing 7 M urea. The gel was run at constant 
voltage (1800 V). The gel was dried and exposed to an imaging plate. 
The radioactivity was analyzed by a bioimaging analyzer, FUJI 
BAS2000. 
Abbreviations: A, 2'-deoxyadenosine; G, 2'-deoxyguanosine; C, 2'- 
deoxycytidine; T, thymidine; M, 5-methyl-2'-deoxycytidine; Um, 2'-0- 
methyluridine; Cm, 2'-O-methylcytidine; TFO, triple helix forming 
oligonucleotide; TM, thrombomodulin; OP, 1,10-phenanthroline; OP- 
oligo, OP-linked oligonucleotide; ODN, oligodeoxynucleotide; MPA, 
I]-mercaptopropionic acid; OP-m, OP-linked 2'-O-methyl RNA; OP-d, 
OP-linked oligodeoxynucleotide. 
2.4. Preparation of labeled 213-bp fragments from the TM gene 
The FokI/BssHII fragment (205 bp) of the TM geue [5] was isolated 
from a 2% Nusieve agarose gel (FMC Bioproducts) by electro-elution. 
The DNA was phenol extracted and ethanol precipitated. The coding 
and noncoding strands were labeled with [~-32P]dCTP and 
[e~-z2p]dTTP, respectively, in the presence of Klenow enzyme (Boeh- 
ringer-Mannheim). The labeled DNA fragment was purified on an 8% 
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non-denaturing el. The isolated DNA was desalted by passage 
through a Nick column (Pharmacia), and was eluted with ultra-pure 
water. 
2.5. Cleavage of 213-bp fragments by OP-TFOs via triple helix 
formation 
For triple helix formation, a 4-I.tl solution of labeled DNA (~0.1 
pmol) and OP-TFO (10 pmol), in a buffer containing 12.5 mM Tris- 
acetate (pH 7.0), 125 mM NaC1, 1.25 mM spermine.4HC1, and carrier 
tRNA (0.5 p.g), was incubated at 37°C for 12 h. 50 I-tM copper sulfate 
(0.5 txl) was added, and the solution was further incubated at 37°C for 
1 h. The cleavage reaction was initiated by adding 100 mM MPA (0.5 
~1). After 20 h at 37°C, the reaction was stopped by freezing with 
liquid nitrogen, and was then lyophilized. The DNA was dissolved in 
5 111 of loading dye containing 80% formamide, and was heat treated 
for denaturing. The cleavage reactions were analyzed on a 5% poly- 
acrylamide gel containing 7 M urea. 
3. Results 
3.1. Design of the OP-linked 2'-O-methyl RNA directed toward 
the promoter egion of the human TM gene via triple helix 
formation 
To test the triple helix formation and the cleavage fficiency 
of an UP-linked 2'-O-methyl RNA (UP-m) on a target site, 
the promoter egion of the human TM gene was chosen. Ac- 
cording to the DNA sequences [5], two adjacent, possible 
triple helix forming sites, with different base compositions, 
are located in this region (Fig. 1). Triplex site 1 contains 
runs of pyrimidines on the coding strand and is a T-rich 
sequence (67% in 12 bp; d-TTCCTTCCTTTT, defined as 
the Y-site). A cluster of purines on the same strand is located 
12 bp downstream, and has a G-rich character (75% in 12 bp; 
d -AGGGAGGGAGGG,  defined as the R-site). These triplex 
sites are included in the regulatory region of the promoter, 
which is called region I [5]. We designed the two UP-ms (12- 
mers), which were expected to cleave the double-stranded 
DNAs individually at the target sites: TMY-m for the Y- 
site and TMR-m for the R-site (Fig. 2). For the control ex- 
periments, two UP-linked oligodeoxynucleotides (OP-ds) with 
different backbones were also designed: TMY-d and TMR-d 
(Fig. 2). The synthesis and purification of the UP derivatives 
of the 5'-thiophosphorylated oligonucleotides were performed 
based on the reported procedure [7]. 
3.2. Cleavage of 32p-labeled 50-mer duplex DNAs 
Synthetic 50-mer DNAs corresponding to the sequence 
from numbers 296 to 345 were prepared (Fig. 1). The coding 
181 Fok I 
T C C CT  GC GC CAGG GC AG GG TT  TACT C..~.~..C .C. C GG CG AG GT G 
ATC CCAT GC GC GAGGGC GG GC GC .qJ~GG GC GG CCAGAGAAC 
296 
CCAGCAATCCGAGTATGCGGCATCAGCCCTTCCCACCAGG 




GAG GC TG CC TC GC AG GG GC TG_C G_CG C.A CG GC/ IA  GAAG T G T 
Fig. 1. Partial nucleic acid sequence of the human thrombomodulin 
gene promoter, containing two possible triplex sites. The coding 
strand is indicated. 
1. OP-oligonucleotides for Y-site 
TMY-m: OP-m(UUUUCCUUCCU)(dT) 
TMY-d: OP-d(TTTTMMTTMMTT) 





~.~..8- P -O-  Op=~NHCOCH2NHOO(CH2)S--No~J 
N.~.J 
Fig. 2. Sequences of OP-oligonucleotides. 
and noncoding strands were 32P-labeled and were each tested 
for chemical cleavage. A large excess (100 equivalents) of the 
OP-oligo was included in the buffer (pH 7.0), containing 
Cu(II) and a reducing agent (MPA). After a 20-h incubation 
at 37°C, the cleavage reactions were analyzed on a 15% de- 
naturing polyacrylamide g l. Specific DNA cleavages of both 
targeted strands were observed in all reactions, and the effi- 
ciencies are summarized in Fig. 3. When TMY-m was used for 
targeting the Y-site, the thymine and protonated cytosine 
bases imparted hydrogen bonding to the purines on the 
non-coding strand, through Hoogsteen base pairing in the 
major groove. The bound oligonucleotides are located in a 
parallel orientation toward the purine strand [1], and the 
UP moiety is localized at the 3' end of the Y-site. The con- 
sequent double-stranded cleavage is considered to be caused 
by an intercalation of the UP moiety from the major groove 
at the duplex-triplex junction: the chelating center for the 
copper ion is located in the minor groove of the target 
DNA [10]. As shown in Fig. 3a, 74% of the cleavage was 
obtained on the labeled noncoding strand, which directly 
base paired with the added TMY-m. On the other hand, 
only 7% cleavage was observed on the complementary coding 
strand. Similar results were obtained when another triplex site 
was targeted using TMR-m (Fig. 3b). At the R-site, TMR-m 
binds to a purine-rich strand, and the resulting cleavage ffÉ- 
ciency was high on the bound coding strand (53%o), as com- 
pared with the noncoding strand (13%). Interestingly, these 
results are characteristic for OP-m and not for OP-d (control). 
Using TMY-d, both the coding and noncoding strands were 
cleaved with similar efficiency: 56% on the noncoding and 
38% on the coding strand. In addition, when the R-site was 
targeted with TMR-d, almost equal efficiency was obtained on 
both strands: 45% on the coding and 51% on the noncoding 
strand. 
3.3. Cleavage of the 213-bp restriction fragment 
As it was shown that the OP-oligos with a 2'-O-methyl 
RNA as a recognition moiety have the ability to cleave the 
target sites of double-stranded DNA, we next applied these 
reagents to the site-specific leavage of a 213-bp restriction 
fragment and tested the cleavage fficiency. Plasmids contain- 
ing a TM promoter sequence [5] were digested with FokI and 
BssHII, and the desired DNA fragment was isolated. Selective 
labeling of either the coding or noncoding strand was per- 
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a. bo 
-CACTT~CTTCCTTTTCCC-  -TCCAG~G~A~G~CC-  
- G T G ~ G G G -  -AGGTCCCTCCCTC~CGG-  
tl' " 
OP--oligo Cleavage (%) OP-,oligo Cleavage (%) 
Coding Noncoding Coding Noncoding 
TMY-m 7 74 TMR-m 53 13 
TMY-d 38 56 TMR-d 45 51 
Fig. 3. Double-stranded cleavage at the two triplex sites of the syn- 
thetic deoxy 50-mer by OP-oligonucleotide conjugates: Y-site (a) 
and R-site (b). Arrows indicate the cleavage sites and the relative in- 
tensities of the reaction when OP-ms were used. DNA regions for 
the triple helix formation are indicated in bold. 
formed by a fill-in reaction with the Klenow enzyme. In the 
presence of [c~-32p]dCTP, the coding strand was labeled at the 
BssHII-cleaved site. In the same manner, the noncoding 
strand was specifically labeled with [a-3zP]dTTP at the FokI- 
cleaved site. 
A DNA fragment, labeled on either the coding or the non- 
coding strand, was incubated with a 100 molar excess of OP- 
m, in a buffer (pH 7.0) containing spermidine at 37°C, for 
triplex formation (12 h). The cleavage reaction was initiated 
by adding copper ion and MPA, as described above for the 
50-mer cleavage. The cleavage products were analyzed on a 
denaturing polyacrylamide g l containing 7 M urea, as shown 
in Fig. 4. The cleavage sites were determined by the chemical 
sequencing of G+A ladders. Specific cleavage of the targeted 
purine strand was observed at the same DNA sequences as 
shown in Fig. 3 by using both OP-m (lanes 1 and 3) and OP-d 
(lanes 2 and 4). Although the overall cleavage ffÉciency was 
lower for OP-m (lane 1 : 59% and lane 3 : 38%), as compared 
to the OP-d (lane 2: 83% and lane 4: 60%), both reagents 
were found to act as site-specific chemical nucleases. 
4. Discussion 
ODNs that bind or react sequence-specifically to double- 
stranded DNA have attracted much attention as biochemical 
tools. For example, TFOs can be used as potential chemother- 
apeutic agents for controlling ene expression at the level of 
transcription [11,12], and OP-oligos can be employed for 
chromosome mapping and the analysis of eukaryotic tran- 
scription units [13]. We describe here the design, synthesis, 
and DNA cleaving activity of OP-m. Although a local triple 
helix was formed by both OP-d and OP-m at the target DNA 
sequence, the cleavage fficiencies on both strands of the du- 
plex were not proportional when the OP-ms were used as 
cleavage agents. These results may reflect he structural differ- 
ences of the respective triple helices and the duplex-triplex 
junctions, formed by the two types of TFOs, 2'-O-methyl 
RNA and DNA. The structural alteration would change the 
geometry of the inserted OP-copper to some extent, and 
would affect the reactivity of the hydroxyl radicals generated 
in situ by the reduction of Cu(II) in the minor groove of the 
DNA [14]. Previous studies indicated that the triple helices of 
duplex DNA and TFO with different sugars have different 
migrations in non-denaturing polyacrylamide gels [2,15]. In 
addition, an affinity cleavage analysis, using TFOs with 
EDTA-Fe as a DNA cleavage agent, showed that the helical 
geometry of the triplex can vary, depending on the backbone 
composition [16]. We assume that the triple-helical structure 
containing T-O-methyl RNA, as a TFO, has more A-like 
structure as compared to the DNA triple helix, because of 
the structural conservatism of the RNA [17]. Based on our 
results, it is possible to design an OP-m single strand-specific 
chemical nuclease by choosing a different linker group [18] to 
change the geometry of the OP insertion into the DNA. A 
promising application of the OP-ms for genome technology is
their use to detect DNA regions that contain the adjacent 
clusters of homopurines and homopyrimidines in the 5' to 
3' direction on the same DNA strand; e.g. such a DNA se- 
quence is found in exon 5 of the hamster adenine phospho- 
ribosyltransferase gene [19]. Since OP-ms were found to work 
as preferential purine strand cutters for duplex DNA, long 
stretches of 5'-protruding ends will be obtained by using 
two OP-ms. A subsequent fill-in reaction with labeled nucleo- 
tides and DNA polymerase (exonuclease-free) will give a 
strong signal on the genomic DNA. On the other hand, a 
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Fig. 4. Site-specific cleavage of the FokI/BssHII fragment of the hu- 
man TM gene promoter by TMR-m (lane 1), TMR-d (lane 2), 
TMY-m (lane 3), and THY-d (lane 4) via oligonucleotide-directed 
triple helix formation. The fragment was labeled with either [a- 
32P]dCTP at the BssHII-cleaved site (C*) or [~-32P]dTTP at the 
FokI-cleaved site (T*). The A+G lane indicates the products of the 
Maxam-Gilbert chemical sequencing reaction. 
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the 5' portion of the OP-m is replaced with a few deoxynu- 
cleotides, may cleave both strands of DNA with equal effi- 
ciency. Structural studies, e.g. NMR studies or X-ray single 
crystal analyses, will be useful to determine the conforma- 
tional differences between the two types of triplexes. The 
TFOs used in this study required cytosine protonations. Our 
data clearly indicate that the triplexes were sufficiently stable 
during the cleavage reaction at a neutral pH (7.0) in the pre- 
sence of 1 mM spermidine. Although the overall cleavage 
efficiency of OP-m was almost equal to or less than the deoxy 
counterparts, the thermal stabilities of these OP-ms were high- 
er than the OP-ds, as indicated by the Tm measurements 
(TMY-m, Tm = 56.6°C; TMY-d, 52.4°C; TMR-m, 69.2°C; 
TMR-d, 53.0°C, at pH 5.0 when the 50-mer DNA was used 
as a target). Since 2'-O-methyl RNA is considered to have 
several advantages over DNA for the formation of a pyrimi- 
dine+purine.pyrimidine-type ri lex, including higher binding 
affinity for duplex DNA [2] even at low salt concentrations [4], 
mismatch discrimination ability [2], and nuclease resistance 
[21], OP-ms can be useful biochemical tools for the cleavage 
of large DNAs. 
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